08/04/2021 | Press release | Distributed by Public on 08/04/2021 18:03
In close coordination with the U.S. Food and Drug Administration (FDA), we have issued a voluntary recall for three SKUs in the Monoject™ Flush Prefilled Syringes (0.9% Sodium Chloride) portfolio, which are intended for use in flushing compatible intravenous tubing systems and indwelling intravascular access devices. The recall applies to all lots of the products distributed between July 2019 and July 2021.
SKU |
Description |
8881570121 |
12mL Syringe, 10 mL Saline Fill |
8881570123 |
12mL Syringe, 3mL Saline Fill |
8881570125 |
12mL Syringe, 5mL Saline Fill |
Our Monoject™ 3mL syringe, 2.5mL Saline Fill is not affected by this recall. This item, SKU 8881570300, will be available for sale until inventory is depleted.
We are issuing the voluntary recall after learning that there is potential for the plunger to draw back after the air has been expelled and reintroduce air back into the syringe. If a clinician is not aware of air being reintroduced into the syringe, air could be inadvertently pushed into the vascular system creating the potential for an air embolism. At this time, Cardinal Health has not received any reports of patient harm or injury related to this issue.
These syringes are different from syringes used to administer COVID-19, flu and other vaccines.
Starting August 5, 2021, customers who may have received affected products will receive notification packets. Customers are instructed to:
Given the limited number of alternative prefilled saline syringe options, combined with ongoing supply, transportation and labor challenges, we anticipate that this recall may contribute to a market disruption of prefilled saline syringes. We are actively working to address the disruption and support customers' needs with locating alternative supply and we suggest that clinicians work with their facility to determine alternative fill methods.
As always, our top priority is the safety of patients, our customers and their healthcare workers. We are committed to helping ensure quality products for our customers and the patients they serve and understand and apologize for any disruption this recall causes in the healthcare system.
In close coordination with the U.S. Food and Drug Administration (FDA), we have issued a voluntary recall for three SKUs in the Monoject™ Flush Prefilled Syringes (0.9% Sodium Chloride)...
Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of...
DUBLIN, Ohio-Cardinal Health WaveMark™ Supply Management & Workflow Solutions has released a whitepaper outlining how automated solutions for inventory management can mitigate supply chain...
Change has been the one constant in nuclear medicine from the beginning, with the steady arrival of new radiopharmaceuticals, new technologies and an evolving regulatory environment. Today, as...